Abstract

IntroductionFemale sexual partners of men who inject drugs (MWID) living with HIV are at risk of HIV transmission. HIV prevalence estimates among non-drug using female sex partners of MWID are scarce, with no studies documenting HIV incidence. We investigated HIV prevalence and incidence among female spouses of MWID registered at Nai Zindagi Trust (NZT), Pakistan, between 2012 and 2019.MethodsNZT registration and service provision data for female spouses who participated in HIV testing and counselling calculated HIV prevalence and incidence using the person years (PY) method. Cox proportional hazards models identified factors associated with incident infection.ResultsOverall HIV prevalence among female spouses of MWID was 8.5%. Among 3478 HIV-negative female spouses, 109 incident infections were observed, yielding an incidence rate of 1.5/100PY (95% CI 1.2–1.8). Independent predictors of incident infection were registration in Punjab province (AHR 1.73 95% CI 1.13–2.68, p = 0.012) and 1–5 years of education (AHR 1.89 95% CI 1.22–2.93, p = 0.004). Knowledge of HIV at registration was protective against infection (AHR 0.51, 95% CI 0.26–0.99, p = 0.047), along with a MWID spouse who had initiated antiretroviral therapy (ART) (AHR 0.25, 95% CI 0.16–0.38, p < 0.001), while incident infection was inversely associated with number of children (≥ 5 children AHR 0.44 95% CI 0.22–0.88, p = 0.022).ConclusionsAdditional efforts are needed to reduce HIV transmission among female spouses of MWID, including targeted provision of HIV education and access to HIV screening. Interventions that target MWID are also required, including evidence-based drug treatment and access to ART, including support to maximize adherence. Finally, consideration should be given to making HIV pre-exposure prophylaxis available to female spouses at high risk of HIV transmission, particularly young women and those whose husbands are not receiving, or have difficulty adhering to, ART.

Highlights

  • Female sexual partners of men who inject drugs (MWID) living with human immunodeficiency virus (HIV) are at risk of HIV transmission

  • A recent systematic review found that women are a growing population of people living with HIV infection, women who live in rural settings and in poverty [7]

  • This study aimed to investigate HIV prevalence and incidence among female spouses of MWID who were registered at Nai Zindagi Trust (NZT) between March 2012 and December 2019 and who received care and support services, including HIV testing and counselling (HTC)

Read more

Summary

Introduction

Female sexual partners of men who inject drugs (MWID) living with HIV are at risk of HIV transmission. Female sexual partners of HIV-positive men who inject drugs (MWID) remain an understudied population, with only nine studies, presenting HIV prevalence estimates among nondrug using female sex partners of HIV-positive MWID globally over the past two decades (since 2000) [9,10,11,12,13,14,15,16,17]. Among these studies, HIV prevalence varied from a high of 45% in Manipur, India, [10, 18] and 35% in KohtlaJärve, Estonia, [9] to a low of 3% in Tehran, Mashhad and Shiraz, Iran [17]. Less is known about incident HIV infection among this group and no studies presenting HIV incidence among non-drug using female sexual partners of HIV-positive MWID were identified

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call